Utama › Amiloidosis › North Carolina
Kajian klinikal Amiloidosis di North Carolina
10 kajian untuk Amiloidosis sedang mencari peserta di lokasi di North Carolina.
Bandar di North Carolina
Teks kajian rasmi (Bahasa Inggeris)
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
- Levine Cancer Institute, Charlotte
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT05652335Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
- Research Site, Durham
Mengambil pesertaKajian pemerhatian
Umur 18 hingga 130 · Semua jantina · Dikemas kini 23 Sep 2026 · NCT06465810TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Clinical Trial Site, Charlotte
Mengambil pesertaFasa 3
Umur 18 hingga 85 · Semua jantina · Dikemas kini 16 Sep 2026 · NCT07052903TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
- Clinical Trial Site, Chapel Hill
Mengambil pesertaFasa 3
Umur 18 hingga 85 · Semua jantina · Dikemas kini 15 Sep 2026 · NCT07223203DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting
- Clinical Trial Site, Charlotte
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Sep 2026 · NCT07358078ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
- Clinical Trial Site, Durham
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 8 Sep 2026 · NCT04561518Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Duke University Medical Center, Durham
Mengambil pesertaFasa 3
Umur 18 hingga 75 · Semua jantina · Dikemas kini 4 Ogo 2026 · NCT06563895A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion
- Atrium Health Levine Cancer Institute /ID# 255074, Charlotte
- Atrium Health Wake Forest Baptist Medical Center /ID# 255851, Winston-Salem
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Mei 2026 · NCT06158854MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
- Duke University Medical Center, Durham
Mengambil pesertaFasa 3
Umur 18 hingga 90 · Semua jantina · Dikemas kini 27 Mac 2026 · NCT06128629Registry for Adults With Plasma Cell Disorders (PCD's)
- North Carolina Cancer Hospital, Chapel Hill
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Nov 2025 · NCT03717844Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.